Compare CCS & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCS | PRGO |
|---|---|---|
| Founded | 2000 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 2014 | 2013 |
| Metric | CCS | PRGO |
|---|---|---|
| Price | $65.59 | $11.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $70.50 | $19.33 |
| AVG Volume (30 Days) | 254.4K | ★ 2.6M |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | 1.77% | ★ 10.18% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.86 | N/A |
| Revenue | ★ $4,117,816,000.00 | $800,000.00 |
| Revenue This Year | N/A | $0.02 |
| Revenue Next Year | $10.84 | $1.36 |
| P/E Ratio | $13.49 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $50.42 | $11.30 |
| 52 Week High | $76.00 | $29.41 |
| Indicator | CCS | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 37.94 | 24.50 |
| Support Level | $61.61 | N/A |
| Resistance Level | $64.48 | $15.08 |
| Average True Range (ATR) | 2.34 | 0.59 |
| MACD | -1.03 | -0.36 |
| Stochastic Oscillator | 10.79 | 6.70 |
Century Communities Inc is engaged in the development, design, construction, marketing, and selling of single-family attached and detached homes. It has five homebuilding segments: West, Mountain, Texas, Southeast, and Century Complete. Its sixth reportable segment is financial services operations, which provides mortgage, title, and insurance services to homebuyers. It has acquired land for homebuilding operations with the primary intent to develop and construct single-family detached or attached homes for sale on the acquired land. The company sells homes through its sales representatives and independent real estate brokers. The company generates the majority of its revenue from the Mountain segment.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.